Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

My Subscriptions My Account My Orders Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Estimates
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

KPIs & Operating Metrics(New)

Alliance Revenue Breakdown Annual Alliance Revenue By Category Andexxa Revenue By Region Andexxa Revenue By Region Annual Arimidex Revenue By Region Annual Assets By Region Atacand Revenue By Region Annual Bevespi Revenue By Region Bevespi Revenue By Region Annual Beyfortus Revenue By Region Beyfortus Revenue By Region Annual Breakdown Of Assets Breztri Revenue By Region Breztri Revenue By Region Annual Brilinta Revenue By Region Brilinta Revenue By Region Annual Bydureon Revenue By Region Bydureon Revenue By Region Annual Byetta Revenue By Region Annual Calquence Revenue By Region Calquence Revenue By Region Annual Cardiovascular And Metabolic Diseases Cardiovascular And Metabolic Diseases Annual Cardiovascular And Metabolic Diseases+B2 Casodex Revenue By Region Annual Collaboration Revenue By Category Collaboration Revenue By Category Annual Crestor Revenue By Region Crestor Revenue By Region Annual Daliresp Revenue By Region Daliresp Revenue By Region Annual Employee Statistics Enhertu Revenue By Region Enhertu Revenue By Region Annual Farxiga Revenue By Region Farxiga Revenue By Region Annual Fasenra Revenue By Region Fasenra Revenue By Region Annual Faslodex Revenue By Region Faslodex Revenue By Region Annual Flumist Revenue By Region Flumist Revenue By Region Annual Global Pharmaceutical Sales By Region Annual Imfinzi Revenue By Region Imfinzi Revenue By Region Annual Iressa Revenue By Region Annual Kanuma Revenue By Region Kanuma Revenue By Region Annual Koselugo Revenue By Region Koselugo Revenue By Region Annual Lokelma Revenue By Region Lokelma Revenue By Region Annual Lynparza Revenue By Region Lynparza Revenue By Region Annual New Crvm Revenue By Region New Crvm Revenue By Region Annual Nexium Revenue By Region Nexium Revenue By Region Annual Non Gaap Profitability Non Gaap Profitability %Non Gaap Profitability Annual Non Gaap Profitability Annual %Oncology Revenue By Region Oncology Revenue By Region Annual Oncology Sales Oncology Sales Annual Onglyza Revenue By Region Onglyza Revenue By Region Annual Operating Profit/ (Loss) By Geographic Areas Operating Profit/ (Loss) Margin By Geographic Areas Opex As A % Of Revenue OPEX Segregation Orpathys Revenue By Region Orpathys Revenue By Region Annual Other Medicines Sales Other Product Sales Annual Other Revenue By Region Other Revenue By Region Annual Others Crvm Revenue By Region Others Crvm Revenue By Region Annual Others Medicines Revenue By Region Others Medicines Revenue By Region Annual Others Oncology Revenue By Region Others Oncology Revenue By Region Annual Others Respiratory Revenue By Region Others Respiratory Revenue By Region Annual Product Revenue Breakdown Annual Product Revenue By Region Annual Product Revenue By Region Annual %Product Revenue By Segment Product Revenue By Segment %Property, Plant And Equipment Breakdown Property, Plant And Equipment By Region Pulmicort Revenue By Region Pulmicort Revenue By Region Annual Rare Disease Product Sales Rare Disease Revenue By Region Rare Disease Revenue By Region Annual Respiratory Revenue By Region Respiratory Revenue By Region Annual Respiratory Sales Respiratory Sales Annual Revenue By Business Vertical Revenue By Business Vertical %Revenue By Business Vertical Annual Revenue By Business Vertical Annual %Revenue By Geogrtaphic Areas Revenue By Region Revenue By Region %Roxadustat Revenue By Region Saphnelo Revenue By Region Saphnelo Revenue By Region Annual Seloken/Toprol Xl Revenue By Region Seloken/Toprol Xl Revenue By Region Annual Soliris Revenue By Region Soliris Revenue By Region Annual Strensiq Revenue By Region Strensiq Revenue By Region Annual Symbicort Revenue By Region Symbicort Revenue By Region Annual Synagis Revenue By Region Synagis Revenue By Region Annual Tagrisso Revenue By Region Tagrisso Revenue By Region Annual Tezspire Revenue By Region Tezspire Revenue By Region Annual Total Assets By Geographic Area Ultomiris Revenue By Region Ultomiris Revenue By Region Annual Vaccines & Immune Revenue By Region Vaccines & Immune Revenue By Region Annual Vaccines & Immune Sales Vaxzevria Revenue By Region Vaxzevria Revenue By Region Annual Zoladex Revenue By Region Zoladex Revenue By Region Annual

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Acquisitions Amortization Capital Expenditures Cash from Discontinued Operations Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Acquisitions & Divestments Change in Intangibles Change in Working Capital Depreciation & Amortization (CF)Dividends Paid - Common Exchange Rate Effect Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Other financing activities Sales of Property, Plant and Equipment Share-based Compensation

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Market Capitalization Price Price to Book Price to Earnings Price to Sales

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)Dividends Paid - Common (QoQ)Dividends Paid - Common Growth (1y)Dividends Paid - Common Growth (3y)Dividends Paid - Common Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)FCF Payout Ratio (QoQ)FCF Payout Ratio Growth (1y)FCF Payout Ratio Growth (3y)FCF Payout Ratio Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)

Income Statement

Amortization - Intangibles Consolidated Net Income Cost of Revenue EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Gross Profit Income from Continuing Operations Income from Non-Controlling Interests Income towards Parent Company Interest & Investment Income Interest Expenses Net Income - Minority Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Other Operating Expenses Profit After Tax Research & Development Restructuring Costs Revenue Selling, General & Administrative Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)

Others

EBIAT Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments R&D In Process Receivables Refunds Shares Issued Shares Repurchased Short-Term Debt issuances

Ratios

Asset Utilization Ratio Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin FCF Payout Ratio Gross Margin Interest Coverage Ratio Inventory Average Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales Times Interest Earned

Astrazeneca (AZN) Selling, General & Administrative (2016 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount